全文获取类型
收费全文 | 8283篇 |
免费 | 464篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 265篇 |
妇产科学 | 129篇 |
基础医学 | 1160篇 |
口腔科学 | 230篇 |
临床医学 | 702篇 |
内科学 | 1897篇 |
皮肤病学 | 126篇 |
神经病学 | 654篇 |
特种医学 | 382篇 |
外国民族医学 | 3篇 |
外科学 | 1501篇 |
综合类 | 189篇 |
一般理论 | 1篇 |
预防医学 | 573篇 |
眼科学 | 96篇 |
药学 | 396篇 |
中国医学 | 6篇 |
肿瘤学 | 383篇 |
出版年
2022年 | 53篇 |
2021年 | 139篇 |
2020年 | 89篇 |
2019年 | 101篇 |
2018年 | 146篇 |
2017年 | 138篇 |
2016年 | 103篇 |
2015年 | 146篇 |
2014年 | 174篇 |
2013年 | 244篇 |
2012年 | 323篇 |
2011年 | 374篇 |
2010年 | 217篇 |
2009年 | 200篇 |
2008年 | 316篇 |
2007年 | 387篇 |
2006年 | 344篇 |
2005年 | 332篇 |
2004年 | 327篇 |
2003年 | 316篇 |
2002年 | 292篇 |
2001年 | 294篇 |
2000年 | 257篇 |
1999年 | 253篇 |
1998年 | 125篇 |
1997年 | 124篇 |
1996年 | 101篇 |
1995年 | 74篇 |
1994年 | 75篇 |
1993年 | 57篇 |
1992年 | 139篇 |
1991年 | 127篇 |
1990年 | 151篇 |
1989年 | 162篇 |
1988年 | 136篇 |
1987年 | 148篇 |
1986年 | 137篇 |
1985年 | 147篇 |
1984年 | 121篇 |
1983年 | 98篇 |
1982年 | 46篇 |
1980年 | 60篇 |
1979年 | 96篇 |
1978年 | 65篇 |
1977年 | 57篇 |
1975年 | 52篇 |
1974年 | 63篇 |
1973年 | 51篇 |
1972年 | 64篇 |
1970年 | 48篇 |
排序方式: 共有8775条查询结果,搜索用时 15 毫秒
971.
Evidence of both ontogeny and transplant dose-regulated expansion of hematopoietic stem cells in vivo 总被引:3,自引:11,他引:3
Recent assessment of the long-term repopulating activity of defined subsets of hematopoietic cells has offered new insights into the characteristics of the transplantable stem cells of this system; however, as yet, there is very little known about mechanisms that regulate their self-renewal in vivo. We have now exploited the ability to quantitate these cells using the competitive repopulating unit (CRU) assay to identify the role of both intrinsic (ontological) and extrinsic (transplanted dose-related) variables that may contribute to the regulation of CRU recovery in vivo. Ly5.1 donor cells derived from day-14.5 fetal liver (FL) or the bone marrow (BM) of adult mice injected 4 days previously with 5-fluorouracil were transplanted at doses estimated to contain 10, 100, or 1,000 long-term CRU into irradiated congenic Ly5.2 adult recipient mice. Eight to 12 months after transplantation, there was a complete recovery of BM cellularity and in vitro clonogenic progenitor numbers and a nearly full recovery of day-12 colony-forming unit-spleen numbers irrespective of the number or origin of cells initially transplanted. In contrast, regeneration of Ly5.1+ donor-derived CRU was incomplete in all cases and was dependent on both the origin and dose of the transplant, with FL being markedly superior to that of adult BM. As a result, the final recovery of the adult marrow CRU compartment ranged from 15% to 62% and from 1% to 18% of the normal value in recipients of FL and adult BM transplantation, respectively, with an accompanying maximum CRU amplification of 150- fold for recipients of FL cells and 15-fold for recipients of adult BM cells. Interestingly, the extent of CRU expansion from either source was inversely related to the number of CRU transplanted. These data suggest that recovery of mature blood cell production in vivo may activate negative feedback regulatory mechanisms to prematurely limit stem cell self-renewal ability. Proviral integration analysis of mice receiving retrovirally transduced BM cells confirmed regeneration of totipotent lymphomyeloid repopulating cells and provided evidence for a greater than 300-fold clonal amplification of a single transduced stem cell. These results highlight the differential regenerative capacities of CRU from fetal and adult sources that likely reflect intrinsic, genetically defined determinants of CRU expansion but whose contribution to the magnitude of stem cell amplification ultimately obtained in vivo is also strongly influenced by the initial number of CRU transplanted. Such findings set the stage for attempts to enhance CRU regeneration by administration of agents that may enable full expression of regenerative potential or through the expression of intracellular gene products that may alter intrinsic regenerative capacity. 相似文献
972.
973.
R M van Praag R P van Heeswijk S Jurriaans J M Lange R M Hoetelmans J M Prins 《Clinical infectious diseases》2001,33(8):e91-e92
The male genital tract is considered an anatomical reservoir during therapy for human immunodeficiency virus infection, because the blood-testis barrier may prevent antiretroviral drugs (e.g., the protease inhibitors ritonavir, saquinavir and nelfinavir) from entering the male genital tract. To our knowledge, there are currently no available data on the penetration of the nucleoside analogue abacavir into the male genital tract. Our report shows that abacavir has good penetration into the male genital tract. 相似文献
974.
975.
Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock 总被引:8,自引:0,他引:8
Kohsaka S Menon V Lowe AM Lange M Dzavik V Sleeper LA Hochman JS;SHOCK Investigators 《Archives of internal medicine》2005,165(14):1643-1650
BACKGROUND: The role of inflammation in patients with coronary artery disease is emerging. We sought to assess the profile and outcomes of patients with a clinical syndrome of severe systemic inflammation that led to a diagnosis of suspected sepsis in the setting of acute myocardial infarction complicated by cardiogenic shock (CS). METHODS: Patients enrolled in the randomized SHOCK (SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK) trial (n = 302) were divided into those with clinical signs of severe systemic inflammation (eg, fever [94%] or leukocytosis [72%]) that led to a diagnosis of suspected sepsis (n = 54 [18%]) and those without suspected sepsis (controls; n = 243 [80%]). The patients with suspected sepsis were then further subdivided into those who were considered to be potentially infectious (positive culture result ["culture-positive"]; n = 40) and those who were not (negative culture result ["culture-negative"]; n = 14). RESULTS: Severe systemic inflammation was diagnosed 4 and 2 days after the onset of CS in culture-positive and culture-negative patients, respectively. Patients who developed systemic inflammation tended to be younger (P = .05) and to have lower systemic vascular resistance (SVR) near the onset of CS (P = .006). Many culture-positive patients (40%) had undergone coronary artery bypass graft surgery. However, the lower the initial SVR, the higher the risk of developing culture-positive systemic inflammation (P = .01), even after controlling for age and coronary artery bypass graft surgery. A time-dependent model, adjusted for age, showed that culture-positive patients were at significantly higher risk for death than were controls (hazard ratio, 2.22; 95% confidence interval, 1.32-3.76; P = .008). CONCLUSIONS: Almost one fifth of patients with acute myocardial infarction complicated by CS showed clinical signs of severe systemic inflammation, and those who were culture-positive for sepsis had twice the risk of death. The observation of lower SVR at the onset of shock in patients who subsequently had culture-positive systemic inflammation suggests that inappropriate vasodilation may play an important role in the pathogenesis and persistence of shock and in the risk of infection. 相似文献
976.
977.
978.
Johannes Amadeus Ziegelmueller Rüdiger Lange Sabine Bleiziffer 《Journal of thoracic disease》2015,7(9):1548-1555
Calcific aortic stenosis is the most frequent manifestation of valvular heart disease. The preferred treatment for patients of all age groups is surgical aortic valve replacement. Recently, transcatheter aortic valve implantation (TAVI) has become the standard of care for patients that are deemed to be at high risk for open heart surgery. The most common access route for TAVI is the retrograde transfemoral (TF) approach, followed by the antegrade transapical (TA) approach. Both access routes have distinct indications. While the TF route is least invasive and the access of choice at most centers, the apical route is used complementary in patients with poor femoral access. In addition, the TA approach holds various benefits such as a short distance from the operator to the annulus facilitating exact positioning of the valve and the possibility to accommodate larger sheaths. Furthermore, the TA approach not only provides direct access to the aortic valve but also the mitral valve allowing for a wide range of interventions. Various apical closure devices are currently being developed under the premise of increasing overall safety of the TA-TAVI approach by further standardizing the procedure, alleviating left ventricular access and minimizing the risk of complications, such as apical bleeding. The aim of this article is to give an overview of current devices for apical closure. The ideal apical closure device should be easy to put in place, leave a minimum of foreign material, provide complete hemostasis and have a minimal risk of displacement. So far the range of commercially available devices in Europe is very limited with only one CE-certified device on the market and one device that is expected to receive CE-certification soon. Off-the-shelf closure devices could help flatten the initial operator learning curve and facilitate a safe apical access, ultimately leading to an entirely percutaneous TA-TAVI approach. 相似文献
979.
S. Dhami H. Zaman E.‐M. Varga G. J. Sturm A. Muraro C. A. Akdis D. Antolín‐Amérigo M. B. Bilò D. Bokanovic M. A. Calderon E. Cichocka‐Jarosz J. N. G. Oude Elberink R. Gawlik T. Jakob M. Kosnik J. Lange E. Mingomataj D. I. Mitsias H. Mosbech M. Ollert O. Pfaar C. Pitsios V. Pravettoni G. Roberts F. Ruëff B. A. Sin M. Asaria G. Netuveli A. Sheikh 《Allergy》2017,72(3):342-365
980.
Dr. L. Lange 《Der Pneumologe》2015,12(6):474-482